1. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. (1st August 2021) Authors: Abels, C.; Soeberdt, M.; Kilic, A.; Reich, H.; Knie, U.; Jourdan, C.; Schramm, K.; Heimstaedt‐Muskett, S.; Masur, C.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. (2nd March 2021) Authors: Abels, C.; Soeberdt, M.; Kilic, A.; Reich, H.; Knie, U.; Jourdan, C.; Schramm, K.; Heimstaedt‐Muskett, S.; Masur, C.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assimilation of 3D radar reflectivities with an ensemble Kalman filter on the convective scale. (15th March 2016) Authors: Bick, T.; Simmer, C.; Trömel, S.; Wapler, K.; Hendricks Franssen, H.‐J.; Stephan, K.; Blahak, U.; Schraff, C.; Reich, H.; Zeng, Y.; Potthast, R. Journal: Quarterly journal of the Royal Meteorological Society Issue: Volume 142:Number 696(2016) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0307 Changes in Urinary Biomarker Levels Can Predict Treatment Responses in Lupus Nephritis. (15th July 2016) Authors: Wither, J.; Prokopec, S.; Noamani, B.; Bonilla, D.; Touma, Z.; Avila-Casado, C.; Reich, H.; Scholey, J.; Boutros, P.; Fortin, P.; Landolt-Marticorena, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Kilometre‐scale ensemble data assimilation for the COSMO model (KENDA). (23rd March 2016) Authors: Schraff, C.; Reich, H.; Rhodin, A.; Schomburg, A.; Stephan, K.; Periáñez, A.; Potthast, R. Journal: Quarterly journal of the Royal Meteorological Society Issue: Volume 142:Number 696(2016) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0091 A Low Density Granulocyte Gene Expression Signature Distinguishes Between Active Patients with and Without Nephritis in Systemic Lupus Erythematosus (SLE). (9th June 2015) Authors: Wither, J.; Prokopec, S.; Noamani, B.; Bonilla, D.; Touma, Z.; Reich, H.; Scholey, J.; Fortin, P.; Boutros, P.; Landolt-Marticorena, C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important: reply from the authors. (1st August 2021) Authors: Abels, C.; Soeberdt, M.; Kilic, A.; Reich, H.; Knie, U.; Masur, C.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important: reply from the authors. (1st June 2021) Authors: Abels, C.; Soeberdt, M.; Kilic, A.; Reich, H.; Knie, U.; Masur, C.; Szeimies, R.‐M. Journal: British journal of dermatology Issue: Volume 185:Number 2(2021) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗